{
    "title": "FDA panel wants heart failure risk on AstraZeneca drugs",
    "url": "https://www.dailymail.co.uk/wires/ap/article-3038751/FDA-panel-wants-heart-failure-risk-AstraZeneca-drugs.html",
    "date": "2015-04-14",
    "keywords": [
        "heart",
        "failure",
        "study",
        "panel",
        "onglyza",
        "risk",
        "drug",
        "safety",
        "fda",
        "attack",
        "blood",
        "percent",
        "gmt",
        "april",
        "information",
        "kombiglyze",
        "glucose",
        "fernandez",
        "astrazenecas",
        "press",
        "email",
        "washington",
        "health",
        "association",
        "deaththe",
        "food",
        "concern",
        "hospitalization",
        "mortality",
        "labeling",
        "abstention",
        "profile",
        "agency",
        "disease",
        "risksastrazenecas",
        "rate",
        "flow",
        "placebo",
        "company",
        "chance",
        "studyhowever",
        "difficulty",
        "seriousness",
        "stroke",
        "applicability",
        "feel",
        "cardiovascular",
        "dr",
        "robert",
        "professor",
        "university",
        "guidance",
        "part",
        "class",
        "dpp4",
        "cos",
        "januvia",
        "tradjenta",
        "boehringer",
        "ingelheimthe",
        "work",
        "body",
        "insulin",
        "amount",
        "livermerck",
        "monthsleerink",
        "analyst",
        "seamus",
        "investment",
        "note",
        "report"
    ],
    "category": [
        "wires",
        "ap"
    ]
}